ReviewTexas Heart Institute journal2024

Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer.

Allan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.